Point72 Asset Management’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
Other funds holding RMD
VCM
VPM
DAM
Point72 Asset Management's RMD Position: Q3 2023 in Review
Point72 Asset Management sold out of ResMed (RMD) in Q3 2023, closing a stake of 605,243 shares — an estimated $132M sold.
Point72 Asset Management first reported a position in RMD in Q4 2014 and held it in 16 quarters. The position peaked at $132M in Q2 2023. 657 funds tracked by Wall St. Rank hold RMD as of Q3 2023.
- Point72 Asset Management reported no remaining ResMed position as of Q3 2023 after selling out during the quarter.
- Point72 Asset Management sold 605,243 ResMed shares in Q3 2023, an estimated $132M.
- Point72 Asset Management first reported a position in ResMed in Q4 2014 and held it in 16 quarters.
- Point72 Asset Management's ResMed position peaked at $132M in Q2 2023.
- 657 funds tracked by Wall St. Rank held ResMed as of Q3 2023.
Based on Point72 Asset Management's 13F filing for Q3 2023, filed 14 Nov 2023.